Statin therapy is associated with reduced neuropathologic changes of alzheimer disease

Neurology

Volumn 71, Issue 5, 2008, Pages 383-

  Siegel, George J ^a   Chauhan, Neelima B ^a   Feinstein, Douglas L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NEUROPROTECTIVE AGENT;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL; BRAIN; DISEASE MODEL; DOSE RESPONSE; DOWN REGULATION; DRUG ADMINISTRATION; DRUG EFFECT; EARLY DIAGNOSIS; HYPERCHOLESTEROLEMIA; METABOLISM; METHODOLOGY; MOUSE; NEUROFIBRILLARY TANGLE; NOTE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG ADMINISTRATION SCHEDULE; EARLY DIAGNOSIS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MICE; NEUROFIBRILLARY TANGLES; NEUROPROTECTIVE AGENTS; PLAQUE, AMYLOID; RESEARCH DESIGN;

EID: 67649450367     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000324089.63164.16     Document Type: Letter

References (2)

1. Li G Larson EB Sonnen JA Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease Neurology 69 2007 878 885
2. Chauhan NB Siegel GJ Feinstein DL Effects of lovastatin and pravastatin on amyloid processing and inflammatory response in TgCRND8 brain Neurochem Res 29 2005 1897 1911